查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1829255

2025年結核病診斷全球市場報告

Tuberculosis Diagnostics Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，結核病診斷市場規模強勁成長，從2024年的22.1億美元增加至2025年的23.4億美元，複合年成長率為5.9%。這段時期的成長歸因於結核病發病率上升、醫療支出增加、醫療機構數量增加以及核酸檢測普及率提高。

預計未來幾年結核病診斷市場規模將強勁成長，2029年將達到31.5億美元，複合年成長率為7.7%。預測期內的成長可歸因於政府的大力支持、美國食品藥物管理局（FDA）對結核病診斷產品核准的不斷增加、研發活動的活性化以及抗藥性結核病的出現。預測期內的主要趨勢包括：關注結核病診斷的新一代定序 (NGS) 平台、產品創新、結核病感染的T細胞​​檢測、基於人工智慧 (AI) 的結核病診斷、攜帶式設備的使用以及政府與製造商的合作。

結核病診斷技術包括用於診斷結核病和監測治療結果的高靈敏度和特異性工具和檢測方法。這些檢測旨在識別臨床檢體中的抗酸桿菌 (AFB) 並檢測結核病。

結核病診斷市場包括各種類型的測試，例如X光、實驗室測試、細胞激素測試、細胞因子檢測測試、抗藥性測試、皮膚測試（TST）/ Mantoux測試、血液/血清學測試、塗片顯微鏡檢查、基於細胞培養的測試和其他方法。 X光用於識別指示結核病症狀的胸部異常。這些測試著重於診斷可能出現在肺部任何位置的病變，包括空腔、密度、大小和形狀的變化。這些診斷方法包括核酸檢測（NAT）、皮膚測試或Mantoux測試（TST）、血液/血清學測試、塗片顯微鏡檢查、基於細胞培養的測試、放射線照相術和其他方法。這些測試針對結核病的各個階段，包括潛伏性結核病和活動性結核病。結核病診斷的最終使用者包括醫院、診斷實驗室、臨床實驗室、參考實驗室、學術機構和研究機構。

2025年春季美國關稅的突然上調及其引發的貿易摩擦對醫療設備行業產生了重大影響，尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制價格上漲，製造商面臨利潤壓力。監管挑戰使情況更加複雜，因為由於關稅而更換供應商通常需要重新認證醫療設備，導致市場進入延遲。為此，企業正在透過雙重採購關鍵零件、加強標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分，該系列提供結核病診斷市場統計數據，例如全球結核病診斷行業規模、各地區佔有率、結核病診斷市場佔有率競爭對手、詳細的結核病診斷細分市場、市場趨勢和商業機會，以及您在結核病診斷行業取得成功所需的數據。本結核病診斷市場研究報告對該行業的現狀和未來趨勢進行了詳細分析，為您提供所需的一切觀點。

未來五年7.7%的預測成長率，較我們先前對該市場的預測略有下降0.5%。下降的主要原因是美國與其他國家之間的關稅影響。由於來自法國和印度等主要地區的分枝桿菌培養基和基因萃取物試劑盒組件的供應鏈中斷，美國可能會直接感受到這一影響，這可能導致檢測延遲並增加結核病篩檢計畫的成本。

結核病 (TB) 發病率的不斷上升推動了結核病診斷市場的需求。結核病是嚴重的感染疾病，主要影響肺部，透過咳嗽和打噴嚏時釋放到空氣中的微小細菌傳播。有效的結核病診斷方法在疾病的早期發現和診斷中發揮關鍵作用。例如，2023 年 3 月，美國國家公共衛生機構疾病管制與預防中心 (CDC) 報告稱，2022 年美國結核病病例數為 8,300 例，高於 2021 年的 7,874 例。結核病病例的增加正在推動結核病診斷市場的成長。

美國食品藥物管理局(FDA)核准的結核病診斷產品數量不斷增加，預計將進一步推動市場成長。例如，2023 年 3 月，英國醫療診斷公司 PerkinElmer Oxford Immunotec 宣布，已獲得 FDA核准使用另外兩種細胞分離設備，即 Allsheng Instruments 生產的 Auto-Pure 24 和 Auto-Pure 20B 平台。此外，2022 年 10 月，PerkinElmer Oxford Immunotec 獲得 FDA核准使用其 T-Cell Select試劑組，有助於獲得認可的實驗室實現體外診斷 (IVD) T-SPOT.TB 檢測工作流程的自動化。 T-Cell Select 是一種周邊血單核細胞 (PBMC) 分離試劑，它透過以微珠為基礎的細胞分離對 PBMC 進行陽性選擇，從而簡化了 T-SPOT.TB 測試的細胞製備，T-SPOT.TB 測試是一種受國際監管的 ELISPOT IGRA，旨在檢測潛伏性結核感染。預計 FDA 對新型結核病診斷核准的批准將加強並推動結核病診斷市場的成長。

影響結核病診斷市場的一個共同趨勢是技術創新的採用，主要市場參與企業積極採用先進技術以保持其市場地位。特別是，利用人工智慧 (AI) 技術的先進照護現場(POC) 方法的採用正在取得進展。一個例子是日本醫學影像設備製造商富士膠片與專門從事基於 AI 的醫學影像解決方案的美國公司 Qure.ai 之間的合作。 2022 年 8 月，兩家公司聯合宣布了一種利用電池供電的X光設備進行結核病診斷的先進即時診斷方法。人工智慧演算法的整合增強了測試程序，為照護現場診斷提供了一種超可攜式、高精度和高效的解決方案。

結核病診斷市場的一個顯著趨勢是，隨著企業努力保持競爭力並滿足不斷變化的消費者需求和偏好，他們越來越注重產品創新。產品創新在吸引愛好者、推動銷售和提高品牌知名度方面發揮關鍵作用。結核病診斷領域的企業正積極致力於開發新的產品解決方案，以鞏固其市場地位。一個值得注意的例子是印度技術力增強型診斷服務供應商Redcliffe Labs，該公司於 2023 年 2 月推出了 BD MAX MDR TB（結核病）測試。此診斷測試在 BD MAX 分子診斷系統上進行，使臨床醫生能夠快速檢測結核病和多重抗藥性作為第一線測試。臨床醫生使用該測試來檢測致結核病細菌，同時確定細菌是否表現出與對兩種重要的一線藥物異煙肼 (INH) 和利福平 (RIF) 的抗藥性相關的突變。這種對產品創新的關注對於加強公司在結核病診斷市場的地位至關重要。

2023年8月，總部位於美國的科技公司丹納赫集團以每股約24美元的價格收購了Abcam plc，總價超過57億美元。此次收購旨在利用Abcam plc豐富的高品質試劑和抗體產品組合，鞏固丹納赫集團在生命科學領域的地位。這將增強丹納赫在科學研究開發方面的能力，並滿足市場對先進生物研究工具日益成長的需求。總部位於英國的生技公司Abcam plc也提供結核病診斷產品。

結核病診斷市場的主要企業包括 Beckton、Dickinson and Company、F. Hoffmann-La Roche Ltd、Qiagen NV、BioMerieux SA、Danaher Corporation、PerkinElmer、Thermo Fisher Scientific Inc、Creative Diagnostics、Lionex GmbH、Biocartis、BioTech-Tech Scientific Inc、Creative Diagnostics、Lionex GmbH、Biocartis、BioTech-Tech Scientific Inc、Creative Diagnostics.Lionex GmbH、Biocartis、BioTech-Tech Scientific Inc、Creative Diagnostics.Lionex GmbH、Biocartis、BioTech-Tech Scientific Inc、Creative Diagnostics.Lionex GmbH、Biocartis、BioTech-Tech Scientific Inc、Creative Diagnostics.Lionex GmbH、Biocartis、BioTech-Tech Scientific Inc. Clinical Laboratories、廣州金域醫學檢驗中心有限公司、Kindstar Global、OriGene Technologies、Siemens AG、LumiraDx Limited、TestLine Clinical Diagnostics sro、Hologic、Bayer AG、Meridian Bioscience、Agilott laboratories Immunagnostices​​an Pc​​yagnostic Holdings Holdings Psa gilnotech、Atechnxia Inc. Limited、Gen-Probe、Sysmex South Africa (Pty) Ltd.、Bio Certica 和 BixBio。

2024 年，亞太地區是結核病診斷市場最大的地區。結核病診斷市場報告涵蓋的地區包括亞太地區、西歐、中歐和東歐、北美、南美以及中東和非洲。

結核病診斷市場報告涵蓋的國家有澳洲、巴西、中國、法國、德國、印度、印尼、日本、俄羅斯、韓國、英國、美國、義大利、西班牙和加拿大。

結核病診斷市場涵蓋提供診斷實驗室方法、潛伏感染檢測、抗藥性檢測和診斷實驗室檢測相關服務的營業單位的收益。市場規模還包括服務提供者銷售或包含在其服務產品中的相關商品的價值。僅包括營業單位之間交易或銷售給最終消費者的商品和服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球結核病診斷：PESTEL分析（政治、社會、科技、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球結核病診斷市場：成長率分析
  • 全球結核病診斷市場表現：規模與成長，2019-2024
  • 全球結核病診斷市場預測：規模與成長，2024-2029年，2034年
  • 全球結核病診斷：總目標市場（TAM）

第6章 市場細分

  • 全球結核病診斷市場（按檢測類型、表現和預測），2019-2024 年、2024-2029 年、2034 年
  • 放射線檢查
  • 核酸檢測
  • 細胞激素檢測試驗
  • 抗藥性檢測
  • 皮膚測試/結核菌素試驗 (TST)
  • 血液/血清檢測
  • 塗片顯微鏡檢查
  • 細胞培養測試
  • 其他
  • 全球結核病診斷市場（依疾病階段、表現及預測），2019-2024 年、2024-2029 年、2034 年
  • 潛伏性結核病
  • 活動性結核病
  • 全球結核病診斷市場（按最終用戶、績效和預測），2019-2024 年、2024-2029 年、2034 年
  • 醫院和診斷實驗室
  • 門診檢查室
  • 參考實驗室
  • 學術研究設施
  • 全球結核病診斷市場：放射學細分市場、類型、表現和預測，2019-2024 年、2024-2029 年、2034 年
  • 胸部X光檢查
  • 電腦斷層掃描
  • 全球結核病診斷市場：核酸檢測細分市場，按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 聚合酵素鏈鎖反應（PCR）
  • 核酸增幅檢查（NAAT）
  • 全球結核病診斷市場：細胞激素檢測測試細分（按類型、表現和預測），2019-2024 年、2024-2029 年、2034 年
  • 干擾素-γ釋放試驗（IGRA）
  • 全球結核病診斷市場：抗藥性檢測細分、類型、績效及預測（2019-2024、2024-2029、2034）
  • GeneXpert MTB/RIF
  • 線探針分析
  • 全球結核病診斷市場：皮膚測試/結核菌素試驗（TST）細分，按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 結核菌素皮膚試驗（TST）
  • 全球結核病診斷市場：血液/血清學檢測細分，按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 抗體血清學檢測
  • 全球結核病診斷市場：塗片顯微鏡細分、類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 抗酸桿菌（AFB）塗片檢查
  • 全球結核病診斷市場：基於細胞培養的測試細分、類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 固態培養基培養
  • 液體培養基培養
  • 全球結核病診斷市場：其他細分市場、按類型、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 分子檢測
  • 先進的成像技術

第7章 區域和國家分析

  • 全球結核病診斷市場：2019-2024 年、2024-2029 年和 2034 年區域表現和預測
  • 全球結核病診斷市場：國家、績效及預測（2019-2024、2024-2029、2034）

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 結核病診斷市場：競爭格局
  • 結核病診斷市場：公司簡介
    • Beckton, Dickinson and Company
    • F. Hoffmann-La Roche Ltd
    • Qiagen NV
    • BioMerieux SA
    • Danaher Corporation

第31章：其他領先和創新企業

  • PerkinElmer
  • Thermo Fisher Scientific Inc.
  • Creative Diagnostics
  • Lionex GmbH
  • Biocartis
  • Bio-Techne India Private Limited
  • Bio-Rad Laboratories India Pvt.Ltd
  • Zhejiang Di'an Diagnostics Technology Co., Ltd
  • ADICON Clinical Laboratories
  • Guangzhou Kingmed Diagnostics Center Co. Ltd.
  • Kindstar Global
  • OriGene Technologies
  • Siemens AG
  • LumiraDx Limited
  • TestLine Clinical Diagnostics sro

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第35章：市場潛力大的國家與策略

  • 2029年結核病診斷市場：提供新機會的國家
  • 2029 年結核病診斷市場：細分市場將帶來新機會
  • 2029年結核病診斷市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r26008u

Tuberculosis diagnostics encompass tools or tests characterized by high sensitivity and specificity in diagnosing TB and monitoring treatment effectiveness. They aim to identify acid-fast bacilli (AFB) in clinical samples and detect tuberculosis.

The tuberculosis diagnostics market comprises various types of tests such as radiographic testing, laboratory testing, nucleic acid testing, cytokine detection testing, drug resistance testing, skin test (TST)/Mantoux test, blood/serology tests, smear microscopy tests, cell culture-based tests, and other methods. Radiographic tests are utilized to identify chest abnormalities indicative of tuberculosis symptoms. These tests focus on diagnosing lesions that can manifest anywhere in the lungs, differing in cavitation, density, size, and shape. These diagnostic methods encompass nucleic acid testing (NAT), skin testing or Mantoux test (TST), blood testing or serology tests, smear microscopy, cultured-based tests, radiography tests, and other approaches. They serve various disease stages such as latent tuberculosis and active tuberculosis. End-users of tuberculosis diagnostics include hospitals, diagnostic laboratories, physician's office laboratories, reference laboratories, academic institutions, and research facilities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The tuberculosis diagnostics market research report is one of a series of new reports from The Business Research Company that provides tuberculosis diagnostics market statistics, including tuberculosis diagnostics industry global market size, regional shares, competitors with a tuberculosis diagnostics market share, detailed tuberculosis diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the tuberculosis diagnostics industry. This tuberculosis diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The tuberculosis diagnostics market size has grown strongly in recent years. It will grow from $2.21 billion in 2024 to $2.34 billion in 2025 at a compound annual growth rate (CAGR) of 5.9%. The growth in the historic period can be attributed to the rise in the incidence of tuberculosis, increased healthcare expenditure, growth in the number of healthcare facilities, and the rise in the adoption of nucleic acid testing.

The tuberculosis diagnostics market size is expected to see strong growth in the next few years. It will grow to $3.15 billion in 2029 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to strong government support, the increasing FDA approvals for tuberculosis diagnostics, the increasing research and development (R&D) activities, and the emergence of drug-resistant TB. Major trends in the forecast period include a focus on next-generation sequencing (NGS) platforms for TB diagnostics, product innovations, t-cell tests for TB infection, artificial intelligence (AI)-based tuberculosis diagnostics, use of portable devices, and collaborations between governments and manufacturers.

The forecast of 7.7% growth over the next five years reflects a modest reduction of 0.5% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for mycobacterium culture media and GeneXpert cartridge components, sourced from key regions such as France and India, could lead to testing delays and higher costs for tuberculosis (TB) screening programs.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing incidence of tuberculosis is boosting demand for the tuberculosis diagnostics market. Tuberculosis is a severe infectious disease primarily affecting the lungs and is transmitted through coughing and sneezing, which release tiny germs into the air. Effective tuberculosis diagnostics play a crucial role in early detection and diagnosis of the disease. For example, in March 2023, the Centers for Disease Control and Prevention (CDC), a US-based national public health organization, reported 8,300 cases of tuberculosis (TB) in the United States in 2022, up from 7,874 cases in 2021. This rise in tuberculosis cases is driving growth in the tuberculosis diagnostics market.

The growing number of approvals from the US Food and Drug Administration (FDA) for tuberculosis diagnostics will further bolster market growth. An illustrative instance is the announcement made in March 2023 by PerkinElmer Oxford Immunotec, a UK-based medical diagnostics company, regarding the FDA approval for the use of two additional cell isolation instruments, Auto-Pure 24 and Auto-Pure 20B platforms, manufactured by Allsheng Instruments. Additionally, in October 2022, PerkinElmer Oxford Immunotec received FDA approval for the use of the T-Cell Select reagent kit, facilitating the automation of the T-SPOT.TB test workflow for in vitro diagnostic (IVD) use by certified laboratories. T-Cell Select, a peripheral blood mononuclear cell (PBMC) isolation reagent, employs positive selection of PBMCs with magnetic bead-based cell separation to streamline the preparation of cells for the T-SPOT.TB test-an internationally regulated ELISPOT IGRA designed for detecting latent tuberculosis infection. This influx of FDA approvals for novel tuberculosis diagnostics is anticipated to reinforce and drive the growth of the tuberculosis diagnostics market.

The prevailing trend shaping the tuberculosis diagnostics market is the adoption of technological innovations, with major market players actively integrating advanced technologies to maintain their market standing. Notably, companies are introducing sophisticated point-of-care (POC) diagnostic methods leveraging artificial intelligence (AI) technology. A case in point is the collaboration between Fujifilm, a Japan-based medical imaging device manufacturer, and Qure.ai, a US-based company specializing in AI-enabled medical imaging solutions. In August 2022, they jointly launched an advanced POC diagnostic method utilizing a battery-powered X-ray machine for tuberculosis diagnosis. The integration of artificial intelligence algorithms enhances testing programs, offering ultra-portability, high accuracy, and efficient solutions for point-of-care diagnostics.

A prominent trend in the tuberculosis diagnostics market is the emphasis on product innovations as companies strive to remain competitive and meet evolving consumer needs and preferences. Product innovation plays a pivotal role in generating enthusiasm, driving sales, and increasing brand awareness. Companies in the tuberculosis diagnostics sector are actively focusing on developing new product solutions to fortify their market positions. A noteworthy example is Redcliffe Labs, an India-based technology-empowered diagnostics service provider, which, in February 2023, introduced the BD MAX MDR TB (Tuberculosis) test. This diagnostic test, performed on the BD MAX molecular diagnostic system, enables clinicians to rapidly test for tuberculosis and multidrug resistance as a first-line test. Clinicians use the test to simultaneously detect bacteria causing TB and ascertain whether the bacteria exhibit mutations associated with resistance to two vital first-line drugs, Isoniazid (INH) and Rifampicin (RIF). This focus on product innovation is integral to strengthening companies' positions within the tuberculosis diagnostics market.

In August 2023, Danaher Corporation, a US-based science and technology company, acquired Abcam plc for approximately $24.00 per share, totaling over $5.7 billion. This acquisition aims to bolster Danaher Corporation's position in the life sciences sector by utilizing Abcam plc's extensive portfolio of high-quality reagents and antibodies. This will enhance Danaher's capabilities in scientific research and development, allowing it to better meet the growing demand for advanced biological research tools. Abcam plc, a UK-based biotechnology company, also provides tuberculosis diagnostics.

Major companies operating in the tuberculosis diagnostics market include Beckton, Dickinson and Company, F. Hoffmann-La Roche Ltd, Qiagen N.V, BioMerieux SA, Danaher Corporation, PerkinElmer, Thermo Fisher Scientific Inc., Creative Diagnostics, Lionex GmbH, Biocartis, Bio-Techne India Private Limited, Bio-Rad laboratories India Pvt.Ltd, Zhejiang Di'an Diagnostics Technology Co., Ltd, ADICON Clinical Laboratories, Guangzhou Kingmed Diagnostics Center Co. Ltd., Kindstar Global, OriGene Technologies, Siemens AG, LumiraDx Limited, TestLine Clinical Diagnostics s.r.o., Hologic, Bayer AG, Meridian Bioscience, Abbott laboratories Immunodiagnostic Systems Holdings PLC, Mesa Biotech Inc, Agilent technologies Inc, Akonni Biosystems Inc, Epistem Limited, Gen-Probe, Sysmex South Africa (Pty) Ltd., Bio Certica, BixBio

Asia-Pacific was the largest region in the tuberculosis diagnostics market in 2024. The regions covered in the tuberculosis diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the tuberculosis diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The tuberculosis diagnostics market includes revenues earned by entities by providing services related to diagnostic laboratory methods, detection of latent infection, detection of drug resistance, and diagnostic laboratory testings. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Tuberculosis Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on tuberculosis diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for tuberculosis diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The tuberculosis diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Test Type: Radiographic Tests, Nucleic Acid Testing, Cytokine Detection Tests, Drug Resistance Tests, Skin Test / Mantoux Test (TST), Blood/Serology Test, Smear Microscopy Tests, Cell Culture-Based Tests, Other Test Types
  • 2) By Disease Stage: Latent Tuberculosis, Active Tuberculosis
  • 3) By End-User: Hospitals And Diagnostic Laboratories, Physician's Office Laboratories, Reference Laboratories, Academics And Research Facilities
  • Subsegments:
  • 1) By Radiographic Tests: Chest X-rays; CT Scans
  • 2) By Nucleic Acid Testing: Polymerase Chain Reaction (PCR); Nucleic Acid Amplification Tests (NAATs)
  • 3) By Cytokine Detection Tests: Interferon Gamma Release Assays (IGRAs)
  • 4) By Drug Resistance Tests: GeneXpert MTB/RIF; Line Probe Assays
  • 5) By Skin Test or Mantoux Test (TST): Tuberculin Skin Test (TST)
  • 6) By Blood Or Serology Test: Serological Tests for Antibodies
  • 7) By Smear Microscopy Tests: Acid-Fast Bacilli (AFB) Smear Test
  • 8) By Cell Culture-Based Tests: Solid Media Cultures; Liquid Media Cultures
  • 9) By Other Test Types: Molecular Tests; Advanced Imaging Techniques
  • Companies Mentioned: Beckton, Dickinson and Company; F. Hoffmann-La Roche Ltd; Qiagen N.V; BioMerieux SA; Danaher Corporation; PerkinElmer; Thermo Fisher Scientific Inc.; Creative Diagnostics; Lionex GmbH; Biocartis; Bio-Techne India Private Limited; Bio-Rad laboratories India Pvt.Ltd; Zhejiang Di'an Diagnostics Technology Co., Ltd; ADICON Clinical Laboratories; Guangzhou Kingmed Diagnostics Center Co. Ltd.; Kindstar Global; OriGene Technologies; Siemens AG; LumiraDx Limited; TestLine Clinical Diagnostics s.r.o.; Hologic; Bayer AG; Meridian Bioscience; Abbott laboratories Immunodiagnostic Systems Holdings PLC; Mesa Biotech Inc; Agilent technologies Inc; Akonni Biosystems Inc; Epistem Limited; Gen-Probe; Sysmex South Africa (Pty) Ltd.; Bio Certica; BixBio
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Tuberculosis Diagnostics Market Characteristics

3. Tuberculosis Diagnostics Market Trends And Strategies

4. Tuberculosis Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Tuberculosis Diagnostics Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Tuberculosis Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Tuberculosis Diagnostics Market Growth Rate Analysis
  • 5.4. Global Tuberculosis Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Tuberculosis Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Tuberculosis Diagnostics Total Addressable Market (TAM)

6. Tuberculosis Diagnostics Market Segmentation

  • 6.1. Global Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Radiographic Tests
  • Nucleic Acid Testing
  • Cytokine Detection Tests
  • Drug Resistance Tests
  • Skin Test / Mantoux Test (TST)
  • Blood/Serology Test
  • Smear Microscopy Tests
  • Cell Culture-Based Tests
  • Other Test Types
  • 6.2. Global Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Latent Tuberculosis
  • Active Tuberculosis
  • 6.3. Global Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals And Diagnostic Laboratories
  • Physician's Office Laboratories
  • Reference Laboratories
  • Academics And Research Facilities
  • 6.4. Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Radiographic Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Chest X-rays
  • CT Scans
  • 6.5. Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Nucleic Acid Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Polymerase Chain Reaction (PCR)
  • Nucleic Acid Amplification Tests (NAATs)
  • 6.6. Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Cytokine Detection Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Interferon Gamma Release Assays (IGRAs)
  • 6.7. Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Drug Resistance Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • GeneXpert MTB/RIF
  • Line Probe Assays
  • 6.8. Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Skin Test / Mantoux Test (TST), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Tuberculin Skin Test (TST)
  • 6.9. Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Blood/Serology Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Serological Tests for Antibodies
  • 6.10. Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Smear Microscopy Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Acid-Fast Bacilli (AFB) Smear Test
  • 6.11. Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Cell Culture-Based Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Solid Media Cultures
  • Liquid Media Cultures
  • 6.12. Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Other Test Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Molecular Tests
  • Advanced Imaging Techniques

7. Tuberculosis Diagnostics Market Regional And Country Analysis

  • 7.1. Global Tuberculosis Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Tuberculosis Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Tuberculosis Diagnostics Market

  • 8.1. Asia-Pacific Tuberculosis Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Tuberculosis Diagnostics Market

  • 9.1. China Tuberculosis Diagnostics Market Overview
  • 9.2. China Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Tuberculosis Diagnostics Market

  • 10.1. India Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Tuberculosis Diagnostics Market

  • 11.1. Japan Tuberculosis Diagnostics Market Overview
  • 11.2. Japan Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Tuberculosis Diagnostics Market

  • 12.1. Australia Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Tuberculosis Diagnostics Market

  • 13.1. Indonesia Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Tuberculosis Diagnostics Market

  • 14.1. South Korea Tuberculosis Diagnostics Market Overview
  • 14.2. South Korea Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Tuberculosis Diagnostics Market

  • 15.1. Western Europe Tuberculosis Diagnostics Market Overview
  • 15.2. Western Europe Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Tuberculosis Diagnostics Market

  • 16.1. UK Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Tuberculosis Diagnostics Market

  • 17.1. Germany Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Tuberculosis Diagnostics Market

  • 18.1. France Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Tuberculosis Diagnostics Market

  • 19.1. Italy Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Tuberculosis Diagnostics Market

  • 20.1. Spain Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Tuberculosis Diagnostics Market

  • 21.1. Eastern Europe Tuberculosis Diagnostics Market Overview
  • 21.2. Eastern Europe Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Tuberculosis Diagnostics Market

  • 22.1. Russia Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Tuberculosis Diagnostics Market

  • 23.1. North America Tuberculosis Diagnostics Market Overview
  • 23.2. North America Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Tuberculosis Diagnostics Market

  • 24.1. USA Tuberculosis Diagnostics Market Overview
  • 24.2. USA Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Tuberculosis Diagnostics Market

  • 25.1. Canada Tuberculosis Diagnostics Market Overview
  • 25.2. Canada Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Tuberculosis Diagnostics Market

  • 26.1. South America Tuberculosis Diagnostics Market Overview
  • 26.2. South America Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Tuberculosis Diagnostics Market

  • 27.1. Brazil Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Tuberculosis Diagnostics Market

  • 28.1. Middle East Tuberculosis Diagnostics Market Overview
  • 28.2. Middle East Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Tuberculosis Diagnostics Market

  • 29.1. Africa Tuberculosis Diagnostics Market Overview
  • 29.2. Africa Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Tuberculosis Diagnostics Market Competitive Landscape And Company Profiles

  • 30.1. Tuberculosis Diagnostics Market Competitive Landscape
  • 30.2. Tuberculosis Diagnostics Market Company Profiles
    • 30.2.1. Beckton, Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Qiagen N.V Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. BioMerieux SA Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Tuberculosis Diagnostics Market Other Major And Innovative Companies

  • 31.1. PerkinElmer
  • 31.2. Thermo Fisher Scientific Inc.
  • 31.3. Creative Diagnostics
  • 31.4. Lionex GmbH
  • 31.5. Biocartis
  • 31.6. Bio-Techne India Private Limited
  • 31.7. Bio-Rad Laboratories India Pvt.Ltd
  • 31.8. Zhejiang Di'an Diagnostics Technology Co., Ltd
  • 31.9. ADICON Clinical Laboratories
  • 31.10. Guangzhou Kingmed Diagnostics Center Co. Ltd.
  • 31.11. Kindstar Global
  • 31.12. OriGene Technologies
  • 31.13. Siemens AG
  • 31.14. LumiraDx Limited
  • 31.15. TestLine Clinical Diagnostics s.r.o.

32. Global Tuberculosis Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Tuberculosis Diagnostics Market

34. Recent Developments In The Tuberculosis Diagnostics Market

35. Tuberculosis Diagnostics Market High Potential Countries, Segments and Strategies

  • 35.1 Tuberculosis Diagnostics Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Tuberculosis Diagnostics Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Tuberculosis Diagnostics Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer